Sangamo Therapeutics, Inc. (0R1D.L) stock price, news, quote and history - Yahoo FinancePublished byuk.finance.yahoo.comon •1 min readSangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.0R1D.LSangamo TherapeuticsInc.0R1D.L stock chartInc. stock chartStock ChartStocksQuotesFinanceFTSE 100GBP/USDGBP/EURFTSE 250AIMGOLD FUTURESLearn moreShareLegalReport
